Agilent Technologies Inc banner

Agilent Technologies Inc
F:AG8

Watchlist Manager
Agilent Technologies Inc Logo
Agilent Technologies Inc
F:AG8
Watchlist
Price: 98.14 EUR -0.3%
Market Cap: €28.6B

P/S

4.6
Current
18%
Cheaper
vs 3-y average of 5.6

Price to Sales (P/S) ratio shows how much investors pay for each dollar of a company`s sales. It`s calculated by dividing the company`s market value by its total revenue.

P/S
4.6
=
Market Cap
€32.5B
/
Revenue
$7.1B

Price to Sales (P/S) ratio shows how much investors pay for each dollar of a company`s sales. It`s calculated by dividing the company`s market value by its total revenue.

P/S
4.6
=
Market Cap
€32.5B
/
Revenue
$7.1B

Valuation Scenarios

Agilent Technologies Inc is trading below its 3-year average

If P/S returns to its 3-Year Average (5.6), the stock would be worth €119.71 (22% upside from current price).

Statistics
Positive Scenarios
3/4
Maximum Downside
-47%
Maximum Upside
+27%
Average Upside
3%
Scenario P/S Value Implied Price Upside/Downside
Current Multiple 4.6 €98.14
0%
3-Year Average 5.6 €119.71
+22%
5-Year Average 5.8 €124.46
+27%
Industry Average 5.1 €107.92
+10%
Country Average 2.4 €52
-47%

Forward P/S
Today’s price vs future revenue

Today's Market Cap Revenue Forward P/S
€32.5B
/
Feb 2026
$7.1B
=
4.6
Current
€32.5B
/
Oct 2026
$7.5B
=
4.3
Forward
€32.5B
/
Oct 2027
$8B
=
4.1
Forward
€32.5B
/
Oct 2028
$8.5B
=
3.8
Forward
€32.5B
/
Oct 2029
$9.4B
=
3.5
Forward
€32.5B
/
Oct 2030
$10.4B
=
3.1
Forward
€32.5B
/
Oct 2031
$9.5B
=
3.4
Forward
€32.5B
/
Oct 2032
$10.1B
=
3.2
Forward
€32.5B
/
Oct 2033
$10.6B
=
3.1
Forward

Forward P/S shows whether today’s P/S still looks high or low once future revenue are taken into account.

Peer Comparison

All Multiples
P/S
P/E
All Countries
Close
Market Cap P/S P/E
US
Agilent Technologies Inc
F:AG8
32.5B EUR 4.6 25.2
US
PerkinElmer Inc
LSE:0KHE
936.1B USD 327.8 3 881
US
Thermo Fisher Scientific Inc
NYSE:TMO
174.7B USD 3.9 25.5
US
Danaher Corp
NYSE:DHR
126.7B USD 5.1 34.3
KR
Samsung Biologics Co Ltd
KRX:207940
82.3T KRW 18.1 46.1
CN
WuXi AppTec Co Ltd
SSE:603259
329.9B CNY 7.3 17.3
CH
Lonza Group AG
SIX:LONN
33.1B CHF 5 -119.1
US
Waters Corp
NYSE:WAT
29.5B USD 9.3 45.9
US
IQVIA Holdings Inc
NYSE:IQV
27B USD 1.7 19.9
US
Mettler-Toledo International Inc
NYSE:MTD
25.7B USD 6.4 29.6
US
West Pharmaceutical Services Inc
NYSE:WST
20.7B USD 6.4 38.2

Market Distribution

In line with most companies in the United States of America
Percentile
68th
Based on 11 520 companies
68th percentile
3.9
Low
0 — 1.2
Typical Range
1.2 — 4.1
High
4.1 —
Distribution Statistics
the United States of America
Min 0
30th Percentile 1.2
Median 2.4
70th Percentile 4.1
Max 4 613 274.2

Agilent Technologies Inc
Glance View

Agilent Technologies Inc., a spin-off from Hewlett-Packard in 1999, has cultivated a niche in the vibrant landscape of the life sciences, diagnostics, and applied chemical markets. This California-based company, born from the legacy of one of Silicon Valley’s pioneers, has carved out its identity by providing sophisticated analytical instrumentation, software, services, and consumables for a wide range of applications. Agilent's businesses are stitched together by an underlying technology expertise, which forms the bedrock for its product lines that serve an increasing demand for precise and reliable analytical measurements. From cutting-edge liquid chromatography to mass spectrometry and genetic analysis systems, Agilent's offerings are geared towards supporting research and quality control processes across various industries, including pharmaceuticals, food safety, and environmental testing. The company's commitment to innovation and quality has consistently positioned it as a trusted partner in advancing the capabilities of laboratories worldwide. Agilent's revenue generation hinges on a strategic blend of product sales and services. The core of its business model revolves around not just selling instruments, but also establishing long-term relationships through service agreements, maintenance, and training. This recurring service revenue complements the sale of consumables and parts required for the operation of their sophisticated instruments. Additionally, Agilent has strategically expanded its footprint in the diagnostics market, providing instruments and reagents used in pathology laboratories, further diversifying its income streams. With a deliberate focus on high-growth areas, including genomics and cancer diagnostics, Agilent continues to leverage its technological prowess and industry expertise to capture market share in sectors that are inherently driven by the necessity for innovation and regulatory compliance. Through an intricate balance of hardware sales and consistent after-sale support, Agilent steadily maintains its role as a formidable player in the analytical instrumentation sector.

AG8 Intrinsic Value
111.54 EUR
Undervaluation 12%
Intrinsic Value
Price €98.14
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett